Screening compound: InChI=1S/C23H15N3O2S/c1-2-5-18(6-3-1)23-24-20(15-29-23)16-8-10-17(11-9-16)22-25-21(28-26-22)13-12-19-7-4-14-27-19/h1-15H

Screening compound: InChI=1S/C23H15N3O2S/c1-2-5-18(6-3-1)23-24-20(15-29-23)16-8-10-17(11-9-16)22-25-21(28-26-22)13-12-19-7-4-14-27-19/h1-15H
Screening compound: InChI=1S/C23H15N3O2S/c1-2-5-18(6-3-1)23-24-20(15-29-23)16-8-10-17(11-9-16)22-25-21(28-26-22)13-12-19-7-4-14-27-19/h1-15H alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C23H15N3O2S/c1-2-5-18(6-3-1)23-24-20(15-29-23)16-8-10-17(11-9-16)22-25-21(28-26-22)13-12-19-7-4-14-27-19/h1-15H

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L472-0275

Molecular Formula

C23H15N3O2S (C23 H15 N3 O2 S)

Compound Name

5-[(1E)-2-(furan-2-yl)ethenyl]-3-[4-(2-phenyl-1,3-thiazol-4-yl)phenyl]-1,2,4-oxadiazole

IUPAC name

5-[(1E)-2-(furan-2-yl)ethenyl]-3-[4-(2-phenyl-13-thiazol-4-yl)phenyl]-124-oxadiazole

SMILES

C(c1ccco1)=C/c1nc(-c(cc2)ccc2-c2csc(-c3ccccc3)n2)no1

InChI

InChI=1S/C23H15N3O2S/c1-2-5-18(6-3-1)23-24-20(15-29-23)16-8-10-17(11-9-16)22-25-21(28-26-22)13-12-19-7-4-14-27-19/h1-15H

InChI Key

KATRFPPSHPRBLI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27454980

InChI=1S/C23H15N3O2S/c1-2-5-18(6-3-1)23-24-20(15-29-23)16-8-10-17(11-9-16)22-25-21(28-26-22)13-12-19-7-4-14-27-19/h1-15H in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Akt-Targeted Library (14764 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with InChI=1S/C23H15N3O2S/c1-2-5-18(6-3-1)23-24-20(15-29-23)16-8-10-17(11-9-16)22-25-21(28-26-22)13-12-19-7-4-14-27-19/h1-15H chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C23H15N3O2S/c1-2-5-18(6-3-1)23-24-20(15-29-23)16-8-10-17(11-9-16)22-25-21(28-26-22)13-12-19-7-4-14-27-19/h1-15H?
Check Price and Availability of InChI=1S/C23H15N3O2S/c1-2-5-18(6-3-1)23-24-20(15-29-23)16-8-10-17(11-9-16)22-25-21(28-26-22)13-12-19-7-4-14-27-19/h1-15H, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C23H15N3O2S/c1-2-5-18(6-3-1)23-24-20(15-29-23)16-8-10-17(11-9-16)22-25-21(28-26-22)13-12-19-7-4-14-27-19/h1-15H you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C23H15N3O2S/c1-2-5-18(6-3-1)23-24-20(15-29-23)16-8-10-17(11-9-16)22-25-21(28-26-22)13-12-19-7-4-14-27-19/h1-15H
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C23H15N3O2S/c1-2-5-18(6-3-1)23-24-20(15-29-23)16-8-10-17(11-9-16)22-25-21(28-26-22)13-12-19-7-4-14-27-19/h1-15H
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C23H15N3O2S/c1-2-5-18(6-3-1)23-24-20(15-29-23)16-8-10-17(11-9-16)22-25-21(28-26-22)13-12-19-7-4-14-27-19/h1-15H available by request